- The distribution of genetic mutations correlated with resistance to KRASG12C inhibitors in Chinese patients with lung cancer.Lin, Shengcheng; Ma, Kai; Xu, Yafei; Liu, Xinyi; Huang, Xiaochun; Huang, MengliAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 2022-06-03 To 2022-06-07.
- Analysis of primary and secondary EGFR-TKI resistance mutations evolution in 835 EGFR-mutant Chinese lung cancers.Dong, Xiaorong; Zeng, Dongqiang; Liu, Xinyi; Huang, MengliAnnual Meeting of the American-Association-for-Cancer-Research (AACR), Philadelphia, PA, 2021-04-10 To 2021.
- Effects on immunotherapy of EGFR mutation subtypes in non-squamous NSCLC.Tang, Haibo; Li, Xiaoning; Xie, Wenzhuan; Huang, MengliAnnual Meeting of the American-Association-for-Cancer-Research (AACR), Philadelphia, PA, 2021-04-10 To 2021.
会议论文
KRAS G12 subtypes with co-mutated TP53, LRP1B, STK11, KEAP1 in lung cancer and their impact on TMB levels, PD-L1 expression and overall survival
4阅读
